The Treatment of Retinoblastoma with Four-Drug Regimen Including Cisplatin, Etoposide, Vincristine, and Cyclophosphamide

Author： Varan Ali Kiratli Hayyam Aydın Burca Tarlan Berçin Poyraz Cigdem Beyhan Akyüz Canan Büyükpamukçu Münevver

Publisher： Informa Healthcare

ISSN： 1521-0669

Source： Pediatric Hematology and Oncology, Vol.29, Iss.6, 2012-08, pp. : 529-537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PROLONGED SECOND RESPONSE TO CISPLATIN, ETOPOSIDE, AND IFOSFAMIDE IN A CHILD WITH A RECURRENT BRAINSTEM GLIOBLASTOMA

By Schuller E. Seidl R. Wandl C. Dieckmann K. Slavc I.

Pediatric Hematology and Oncology, Vol. 18, Iss. 4, 2001-06 ,pp. : 253-258

Informa Healthcare

Access to resources Recommend Favorite

PYRIDOXINE AND PYRIDOSTIGMINE TREATMENT IN VINCRISTINE-INDUCED NEUROPATHY

By Ozyurek Hamit Turker Hande Akbalik Mehtap Bayrak Ayse Oytun Ince Hulya Duru Feride

Pediatric Hematology and Oncology, Vol. 24, Iss. 6, 2007-07 ,pp. : 447-452

Informa Healthcare

Access to resources Recommend Favorite

Vincristine treatment for function- and life-threatening infantile hemangioma

By Enjolras O. Breviere G.M. Roger G. Tovi M. Pellegrino B. Varotti E. Soupre V. Picard A. Leverger G.

Archives de Pediatrie, Vol. 11, Iss. 2, 2004-02 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite

A Modified Protocol with Vincristine, Topotecan, and Cyclophosphamide for Recurrent/Progressive Ewing Sarcoma Family Tumors

By Kebudi Rejin Cakir Fatma Betul

Pediatric Hematology and Oncology, Vol. 30, Iss. 3, 2013-03 ,pp. : 170-177

Informa Healthcare

Access to resources Recommend Favorite

ENHANCED VINCRISTINE NEUROTOXICITY FROM DRUG INTERACTIONS: Case Report and Review of Literature

By Sathiapalan Rajeev K. El-Solh Hassan

Pediatric Hematology and Oncology, Vol. 18, Iss. 8, 2001-12 ,pp. : 543-546

Informa Healthcare

Access to resources Recommend Favorite